Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Dec 16;47(26):6435-8.
doi: 10.1021/jm049194+.

Synthesis and Activity of Substituted 4-(indazol-3-yl)phenols as Pathway-Selective Estrogen Receptor Ligands Useful in the Treatment of Rheumatoid Arthritis

Affiliations

Synthesis and Activity of Substituted 4-(indazol-3-yl)phenols as Pathway-Selective Estrogen Receptor Ligands Useful in the Treatment of Rheumatoid Arthritis

Robert J Steffan et al. J Med Chem. .

Abstract

Pathway-selective ligands for the estrogen receptor (ER) inhibit NF-kappaB-mediated inflammatory gene expression causing a reduction of cytokines, chemokines, adhesion molecules, and inflammatory enzymes. SAR development of a series of 4-(indazol-3-yl)phenols has led to the identification of WAY-169916 an orally active nonsteroidal ligand with the potential use in the treatment of rheumatoid arthritis without the classical proliferative effects associated with estrogens.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback